Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
117
Participants
Timeline
Start Date
September 30, 2005
Study Completion Date
May 31, 2006
Conditions
Breast Cancer
Interventions
DRUG
dose dense with neulasta
Trial Locations (1)
B-3000
UZ Gasthuisberg Leuven, Leuven
All Listed Sponsors
collaborator
St-Augustinus Wilrijk
UNKNOWN
lead
Universitaire Ziekenhuizen KU Leuven
OTHER
NCT00256360 - Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer | Biotech Hunter | Biotech Hunter